What if you'd held BDRX?
A $1,000 investment in Biodexa Pharmaceuticals plc (BDRX) at the month-end close of 2015-12 would be worth $0.0000026 at the close of 2026-08 — -100.0% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $3,771.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2015
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2015 | $1,000 | — |
| 2016 | $569 | -43.1% |
| 2017 | $173 | -69.6% |
| 2018 | $31.96 | -81.5% |
| 2019 | $14.21 | -55.5% |
| 2020 | $7.71 | -45.7% |
| 2021 | $4.33 | -43.9% |
| 2022 | $0.81 | -81.2% |
| 2023 | $0.006907 | -99.1% |
| 2024 | $0.0004175 | -94.0% |
| 2025 | $0.0000234 | -94.4% |
| 2026 | $0.0000026 | -88.9% |
Best and worst month-end to buy
The best single month-end close to have bought BDRX was 2026-08 ($1.26): $1,000 then is $1,000 today. The worst was 2015-12 ($485M): $1,000 then is $0.0000026.
FAQ
What would $1,000 in BDRX be worth today?
A $1,000 investment in Biodexa Pharmaceuticals plc (BDRX) at the start of 2015 would be worth about $0.0000026 today, a total return of -100.0%. Dividends are reinvested in these figures.
What were the best and worst years for BDRX?
Biodexa Pharmaceuticals plc (BDRX)'s strongest calendar year since 2015 was 2016, a -43.1% return — $1,000 held through that year became about $569 by year-end. Its weakest year was 2023, at -99.1%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in BDRX have grown?
Investing $100 at the end of every month since 2015-12 would have grown to about $439 on $12,900 invested.
Did BDRX beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $3,771. BDRX trailed the S&P 500 by +100.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Biodexa Pharmaceuticals plc (BDRX) historical total-return data from 2015-12 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.